150,440 Shares in Option Care Health, Inc. $OPCH Bought by Prospector Partners LLC

Prospector Partners LLC acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the third quarter, HoldingsChannel.com reports. The institutional investor acquired 150,440 shares of the company’s stock, valued at approximately $4,176,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in OPCH. Swedbank AB acquired a new position in shares of Option Care Health during the third quarter valued at about $49,455,000. Boston Partners boosted its stake in Option Care Health by 34.8% in the 2nd quarter. Boston Partners now owns 952,299 shares of the company’s stock worth $30,311,000 after purchasing an additional 245,990 shares in the last quarter. Aristides Capital LLC purchased a new stake in Option Care Health during the 2nd quarter worth approximately $249,000. Prudential Financial Inc. increased its stake in Option Care Health by 32.6% during the 2nd quarter. Prudential Financial Inc. now owns 396,158 shares of the company’s stock valued at $12,867,000 after purchasing an additional 97,465 shares in the last quarter. Finally, Pacer Advisors Inc. acquired a new position in Option Care Health during the 3rd quarter valued at approximately $593,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Stephens raised shares of Option Care Health to a “strong-buy” rating in a report on Thursday, December 11th. Barrington Research boosted their price target on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Citigroup restated an “outperform” rating on shares of Option Care Health in a research note on Tuesday, January 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a research report on Monday, December 29th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $37.00 price target on shares of Option Care Health in a report on Tuesday, January 13th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and an average target price of $37.58.

Option Care Health Stock Up 0.7%

Shares of OPCH opened at $35.50 on Thursday. The company has a market capitalization of $5.63 billion, a price-to-earnings ratio of 28.17, a PEG ratio of 2.10 and a beta of 0.84. Option Care Health, Inc. has a 52 week low of $24.24 and a 52 week high of $36.80. The stock’s 50-day moving average price is $33.82 and its 200-day moving average price is $30.29. The company has a quick ratio of 1.05, a current ratio of 1.56 and a debt-to-equity ratio of 0.85.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.